Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0216-2018

Drug recall · January 24, 2018

Shiseido Future Solution LX Discovery Set contains SPF 50+ recall

Why: GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Shiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022,

Lots / codes

SKU#: 95167

Quantity
N/A
Company
Shiseido America Inc., East Windsor, NJ
Distribution
Product was distributed nationwide.
Initiated
December 14, 2017 · Voluntary: Firm initiated
Classified
January 12, 2018
Reported
January 24, 2018
Ended
June 24, 2021
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.